said a spokesperson for the Public Health Agency of Canada. Now multiple studies, including Dormuth's, are shedding light on where Pfizer's drug actually fits into the COVID treatment picture at ...

COVID vaccine booster shots were rolled out, and about 40 percent of US adults said they did not plan on getting a booster.

Sales of Spikevax, the Cambridge company’s only marketed product, plummeted to $167 million from $1.9 billion, the firm ...

Pfizer reports Q1 results: adjusted EPS beats estimates, driven by revenue growth. Significant declines in Comirnaty and ...

One national patient group focused on neurological conditions in Canada pointed out the drug ... like Pfizer, Moderna and ...

Drug maker Pfizer and vaccine experts have also ... of DNA fragments per dose in Pfizer and Moderna’s COVID-19 vaccines in ...

Pfizer has a promising drug in development that targets the novel coronavirus’s ability to replicate. The new drug could help save patients experiencing mild-to-moderate COVID-19 cases ...

Pfizer lifted its annual earnings forecast on Wednesday and reported a first-quarter profit above Wall Street estimates, ...

The statement continued by saying that “Canada ... Pfizer/BioNTech, Moderna, or Johnson & Johnson Covid-19 vaccines, you are not receiving what’s still considered by the U.S. Food and Drug ...

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved BEQVEZ™ (fidanacogene ...

We're in the thick of first-quarter earnings season, and on this week's busy lineup is blue-chip drugmaker Pfizer (PFE ... the company's non-COVID business, with cancer drugs Ibrance and Inlyta ...